ADAMs are multidomain cell surface proteins that function in receptor-ligand processing, cell adhesion and fusion, and signaling. SpADAM, a single copy sea urchin ADAM gene with a 3072 bp open reading frame, is expressed during embryonic and larval development. The deduced SpADAM protein is 1023 amino acids long and includes all domains characteristic of ADAMs. Northern blots reveal the presence of 4.4 and 2.3 kb SpADAM transcripts throughout development. Predominant SpADAM proteins are 131 and 95 kDa. The deduced primary structure of SpADAM is closely related to vertebrate ADAMs 12, 13, and 19. SpADAM is expressed during cleavage on blastomere surfaces, and later by vegetal plate cells, migrating secondary mesenchyme, skeletogenic mesenchyme, muscles, and neurons within the ciliated band. Apparently, the structure and types of cells in which ADAM 12/13/19 orthologues are expressed are conserved in deuterostomes. q
Results and discussion
ADAMs are a family of cell surface molecules, expressed by a diverse group of animals where they have a range of functions. ADAMs have been described in mammals (Wolfsberg et al., 1995; Yagami-Hiromasa et al., 1995; Wolfsberg and White, 1996) , Caenorhabditis elegans (Podbilewicz, 1996) , Xenopus laevis (Alfandari et al., 1997) , and Drosophila (Pan and Rubin, 1997; Sotillos et al., 1997) . ADAMs appear to play important roles in early development (Primakoff and Myles, 2000) . The disintegrin and putative fusogenic domains of some ADAMs may be involved in cell-cell adhesion and fusion during fertilization (Yuan et al., 1997; Evans et al., 1997; Cho et al., 1998) and myotube formation (Yagami-Hiromasa et al., 1995) . The zinc-dependent metalloproteinase domains of some ADAMs have been shown to proteolytically process extracellular domains (Pan and Rubin, 1997; Black et al., 1997; Peschon et al., 1998) . In addition, the cytoplasmic domains of some ADAMs contain motifs characteristic of proteins that participate in signal transduction pathways (Wolfsberg and White, 1996; Weskamp et al., 1996; Howard et al., 1999) .
In vertebrates, ADAM 12 (meltrin a), 13, and 19 (meltrin b) are well characterized ADAMs that are expressed in early development, initially by mesenchyme. Mouse ADAM 12 and Xenopus ADAM 13 are expressed in myoblasts (Yagami-Hiromasa et al., 1995; Alfandari et al., 1997) , and ADAM 12 is involved in myoblast differentiation and fusion (Yagami-Hiromasa et al., 1995; Alfandari et al., 1997; Gilpin et al., 1998; Inoue et al., 1998) . ADAM 12 and ADAM 19 are expressed by osteoblasts and osteoclasts (Inoue et al., 1998; Abe et al., 1999) . ADAM 13, expressed in the neuroectoderm and some cranial neural crest cells in Xenopus embryos (Alfandari et al., 1997) , appears to act in extracellular matrix remodeling during neural crest migration (Alfandari et al., 2001) . Mouse ADAM 19 is expressed in neural crest-derived ganglia and ventral horns of the spinal cord during neurogenesis (Kurisaki et al., 1998) and is capable of proteolytically processing neuregulin (Shirakabe et al., 2001 ), a growth factor involved in the differentiation of neural crest-derived neurons and glia (Meyer and Birchmeier, 1995; Meyer et al., 1997; Cameron et al., 2001; Meintanis et al., 2001 ).
Here we report the cloning and characterization of a novel sea urchin ADAM that is closely related to ADAMs 12, 13, and 19. Like these vertebrate ADAMs, SpADAM is initially expressed in mesenchyme.
SpADAM primary structure and phylogenetic analysis
Homology RT-PCR using mesenchyme blastula mRNA as template and degenerate semi-nested primers (Alfandari et al., 1997) Northern blots reveal 4.4 and 2.3 kb transcripts in cleavage, mesenchyme blastula, early gastrula, and prism stages (Fig. 1C) . Mid-gastrula, late gastrula, and pluteus samples contain only the smaller transcript.
Western blot
Anti-SpADAM antibody strongly recognizes bands at 131 and 95 kDa, and weaker bands at 51 and 44 kDa. Having multiple forms of the SpADAM protein is consistent with the proteolytic processing found in other ADAMs.
In situ hybridization and immunolocalization
Vegetal plates and primary mesenchyme cells (PMCs) Domain boundaries are from Gilpin et al. (1998) . Gaps are indicated by dashes, a large black arrow shows the predicted signal peptide cleavage site (Nielsen et al., 1997) , and asterisks show potential N-linked glycosylation sites. Amino acid identities are shown in gray. The metalloproteinase active site, disintegrin loop, and putative fusogenic peptide, are boxed. SpADAM contains the conserved HEXGHXXGXXHD zinc-binding catalytic site sequence characteristic of active metalloproteinases (Black and White, 1998; Schlöndorff and Blobel, 1999) . The cysteine-rich domains of SpADAM and ADAM 12 (Yagami-Hiromasa et al., 1995; Huovila et al., 1996) contain putative fusogenic peptides that, like viral fusion peptides, are hydrophobic and contain central prolines (Blobel et al., 1992) . The cytoplasmic domain of SpADAM is 22.8% proline and contains sequences such as RPTPVTRP which are similar to the SH3 binding consensus, RPLPXXP. SpADAM Accession number: AY029303. (B) SpADAM domain structure and hydrophilicity profile. Hydrophilicity profile for SpADAM was generated using the Kyte and Doolittle (1982) method for calculating amino acid hydropathy indices. N, amino terminus; SP, signal peptide; EGF, epidermal growth factor; TM, transmembrane; C, carboxyl terminus; aa, amino acid. On the hydrophilicity plot, single bar ¼ hydrophobic signal sequence, double bar ¼ hydrophobic putative fusogenic peptide, and triple bar ¼ hydrophobic transmembrane domain. (C) Northern blot reveals the presence of two SpADAM transcripts, 4.4 and 2.3 kb.
(D) A polyclonal antiserum, raised against a His-tagged bacterially expressed 277 amino acid SpADAM fragment containing all of the disintegrin domain and parts of the metalloprotease and cysteine-rich domains, was used in immunoblots and immunolocalizations. In cleavage stage crude membrane fractions, the dominant protein recognized by anti-SpADAM serum is of apparent MW 131 kDa (black arrow). The 131 kDa band is not present in cleavage stage non-membrane fractions (data not shown). In mesenchyme blastula (28 h) crude membrane fractions, the dominant band is 95 kDa (black arrowhead). Anti-SpADAM antibodies also recognize ahybridize probe in mesenchyme blastulae and early gastrulae (Fig. 3A) . In late gastrulae, SpADAM probe binding is highest in secondary mesenchyme cells (SMCs) as they release from the archenteron tip, as well as in the thickened apical plate and blastopore rim (Fig. 3B) . In prisms (50 h), the highest levels of probe binding are observed in the apical plate, coelomic pouches, intestine, pigment cells, blastocoelar cells, and some PMCs (Fig. 3C,D) . Typically, there is one PMC in each ventrolateral cluster that stains more intensely than the others. In 5 week larvae, the highest levels of SpADAM probe binding are in the ciliated band, epaulettes, vestibule, somatocoels, and the five primary podia of the adult rudiment (Fig. 3F) . SpADAM protein expression is first detected in cleavage (Fig. 4A,C) . In mesenchyme blastulae, the apical surfaces of vegetal plate cells are immunoreactive (Fig. 4D) . As PMCs are released into the blastocoel, some have small foci of anti-SpADAM immunoreactivity on their surfaces. Throughout gastrulation, SMCs released from the tip of the archenteron are immunoreactive (Fig. 4E) . By late gastrula/early prism stage (45 h), skeletogenic cells are highly immunoreactive and they remain immunoreactive throughout larval life (Fig. 4G) . In late gastrulae, the cells of the coelomic pouches and pigment cells dispersed within the ectoderm are immunoreactive (Fig. 4H) . In early plutei the circumesophageal muscle fibers express SpADAM (Fig.  4I) . Preoral ectoderm fluorescence is initially in a small number of cells, but in later plutei, the thickened ectoderm between the preoral arms is fluorescent (Fig. 4H) . SpADAM co-localizes to cells expressing the neuronal marker 1E11 (Nakajima, Kaneko, Murray, and Burke, unpublished data) within the ciliated bands (Fig. 4J) .
The primary structure of SpADAM indicates that it is most closely related to vertebrate ADAMs 12, 19, and 13. These three vertebrate ADAMs are expressed in mesenchyme, which contributes to muscles and bone. In addition, ADAM 13 and 19 are expressed in the neural plate or neural crest cell-derived tissues (Alfandari et al., 1997; Kurisaki et al., 1998) . Like these vertebrate meltrins, SpADAM is expressed in myogenic and skeletogenic mesenchyme and neurons. It appears possible that within the deuterostomes, the structure and the types of cells expressing this group of ADAMs are well conserved. Fig. 2 . Phylogenetic analysis of all ADAMs for which complete cDNA sequence is available. Deduced amino acid sequences, without their signal peptides and cytoplasmic domains, were aligned and a phylogenetic tree constructed using a neighbor-joining algorithm. Bootstrap values are recorded at each node. SpADAM is most similar to human ADAM 12 (34.8% identity/59.5% similarity), Xenopus ADAM 13 (35.5% identity/ 59.0% similarity), Xenopus ADAM 9 (meltrin g) (32.5% identity/59.9% similarity), and mouse ADAM 19 (31.1% identity/57.0% similarity). Within the metalloproteinase active site, the SpADAM sequence is 66.7% identical and 91.7% similar to human ADAM 12, Xenopus ADAM 13, and mouse ADAM 19. Within the disintegrin loop, SpADAM is 78.6% identical and 85.7% similar to human ADAM 12, 57.1% identical and 92.9% similar to Xenopus ADAM 13, and 57.1% identical and 78.6% similar to mouse ADAM 19. Aligned extracellular domains (excluding signal sequences) gave the most robust bootstrap values. Phylogenetic trees were generated for all single domain alignments and all possible multiple domain alignments, including entire sequence (data not shown). In these, the SpADAM sequence always clusters with ADAM 12, ADAM 13, and ADAM 19. Alternative nomenclature and NCBI Accession numbers follow: ADAM 1 (fertilin a), U46069, Y08616; ADAM 2 (fertilin b), AF086808, NM_001464, X99794, U38806, U46070; ADAM 3 (cyritestin), NM_009619; ADAM 5, U22059, U22060; ADAM 7, NM_007402; ADAM 8, NM_001109, NM_007403; ADAM 9 (meltrin g), NM_003816, NM_007404, AF032382; ADAM 10 (kuzbanian, SUP-17), NM_001110, NM_007399, U60591, AF024614; ADAM 11, NM_002390; ADAM 12 (meltrin a), NM_003474, NM_007400; ADAM 13, U66003; ADAM 15 (metargidin), NM_003815, NM_009614, AJ251198; ADAM 17 (tumor necrosis factor a converting enzyme, TACE), NM_003183, NM_009615; ADAM 18, NM_014237; ADAM 19 (meltrin b), NM_009616; ADAM 20, NM_003814; ADAM 21, AF158644; ADAM 22, AF134708; ADAM 23, NM_003812, NM_011780; ADAM 24 (testase 1), AF167402; ADAM 25, NM_011781; ADAM 26 (testase 3), AF167404; ADAM 27, AF167405; ADAM 28, AF153350, NM_014265; ADAM 29, AF171929; ADAM 30, AF171932; ADAM 31, AF251559; ADM-1, U68185; SpADAM, AY029303. 
Methods

Embryo culture
Strongylocentrotus purpuratus were collected locally and kept at 12 8C in recirculating sea water. Embryos were cultured at 12-14 8C following conventional procedures (Strathmann, 1987) .
Homology RT-PCR
Poly (A 1 ) RNA was prepared following Marsden and Burke (1997) . First strand cDNA was used as template in PCR amplifications with primers 1, 5 and 4 from Alfandari et al. (1997) . A 1:500 dilution of first-round product was used as template in a second round of amplification (39 cycles of 94 8C for 1 min, 40 8C for 2 min, 72 8C for 2 min with 10 min extension at 72 8C). Cloned product was sequenced using M13 primers on an ABI 377 automated sequencer. ADAM sequences were aligned using GENE-STREAM alignment tools (IGH Montpellier, France), and DNAMAN (Lyon Biosoft v4.03) was used to construct phylogenetic trees using neighbor-joining algorithms.
Screening lambda and arrayed cDNA libraries
A mid-gastrula l phage cDNA library (Marsden and Burke, 1997) was screened with a 336 bp SpADAM PCR product (1115-1450). A single 1054 bp SpADAM clone was isolated and used to screen 20 h (mesenchyme blastula) and 40 h (late gastrula) high density, arrayed cDNA libraries (E. Davidson, CalTech).
In situ RNA hybridization
A 425 bp SpADAM fragment (1052-1477) was used to transcribe digoxygenin-labeled RNA probes (Ransick et al., 1993) . Embryo fixation and RNA hybridization followed Harkey et al. (1992) .
Northern blot
Following Sambrook et al. (1989) , 1 mg mRNA from each stage was separated on a formaldehyde agarose gel, transferred to nylon filters, and UV crosslinked. The insert from the 1054 bp SpADAM clone was random primed (Gibco) and used as probe. Membranes were hybridized overnight (16-20 h) at 65 8C. Following hybridization, membranes were washed in 2 £ SSC, 0.2% SDS (15 min, 65 8C), twice in 0.2 £ SSC, 0.2% SDS (30 min, 65 8C), and phosphoimaged.
Antibody production
An 832 bp SpADAM fragment (925-1757) was subcloned into the expression plasmid pQE31 (Qiagen). Expression and purification of the 6xHis-tagged SpADAM fragment followed the manufacturer's procedures (Qiagen). Purified SpADAM protein was concentrated (2 mg/ml) and buffer exchanged into sterile PBS. A New Zealand white rabbit was inoculated with 200 mg SpADAM and boosted four times at monthly intervals. Anti-SpADAM serum was collected 14 days after the final boost.
Immunoblots
For each sample, 3 £ 10 4 embryos were pelleted, resuspended in 300 ml water containing Completee protease inhibitor (Boehringer Mannheim), and sonicated (5 s). Samples were then centrifuged at 25,000 £ g (4 8C, 30 min), and supernatants were concentrated 5 £ using Centricon 10 centrifugal filters (Amicon). Samples were dissolved in reducing sample buffer and separated by SDS-PAGE (Laemmli, 1970) , and transferred to nitrocellulose (Towbin et al., 1979) . Blots were blocked, incubated, washed, and detected as in Marsden and Burke (1997) . Antiserum or preimmune serum was diluted 1:1000, and alkaline phosphatase-conjugated goat anti-rabbit (Sigma) was diluted 1:10,000 in 3% milk/TBST (3% skim milk powder, 0.1% Tween 20 in TBS).
Whole mount immunofluorescence
Embryos were fixed following Nakajima and Burke (1996) , and prepared for immunolocalization following Marsden and Burke (1997) . Specimens were viewed and images acquired with a Zeiss LSM 410 laser scanning microscope. Pre-immune serum was used as a control. Images were adjusted for contrast and brightness and assembled with Adobe Photoshop (V. 4.0).
